Skip to content

Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine

C18H19N9 — CID 143464724

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine
SMILESCC.Cn1cc(-c2cnc3c(Nc4cccn5ncnc45)nccn23)cn1
InChIInChI=1S/C16H13N9.C2H6/c1-23-9-11(7-20-23)13-8-18-16-14(17-4-6-24(13)16)22-12-3-2-5-25-15(12)19-10-21-25;1-2/h2-10H,1H3,(H,17,22);1-2H3
InChIKeyBAXLNFLAWUFPMZ-UHFFFAOYSA-N
MW361.41 g/mol
LogP2.94
Rot. Bonds3

About Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine

Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 143464724) has the molecular formula C18H19N9 and a molecular weight of 361.41 g/mol. Its IUPAC name is ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine.

Molecular Properties

Compound NameEthane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine
PubChem CID143464724
Molecular FormulaC18H19N9
Molecular Weight361.41 g/mol
Exact Mass361.18
IUPAC Nameethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine
SMILESCC.Cn1cc(-c2cnc3c(Nc4cccn5ncnc45)nccn23)cn1
InChIInChI=1S/C16H13N9.C2H6/c1-23-9-11(7-20-23)13-8-18-16-14(17-4-6-24(13)16)22-12-3-2-5-25-15(12)19-10-21-25;1-2/h2-10H,1H3,(H,17,22);1-2H3
InChIKeyBAXLNFLAWUFPMZ-UHFFFAOYSA-N
XLogP2.94
TPSA90.23 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500361.41
LogP ≤ 52.94
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine?
The IUPAC name of Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine (CID 143464724) is ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine.
What is the SMILES notation for Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine?
The canonical SMILES for Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine is CC.Cn1cc(-c2cnc3c(Nc4cccn5ncnc45)nccn23)cn1.
What is the InChIKey of Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine?
The InChIKey is BAXLNFLAWUFPMZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H13N9.C2H6/c1-23-9-11(7-20-23)13-8-18-16-14(17-4-6-24(13)16)22-12-3-2-5-25-15(12)19-10-21-25;1-2/h2-10H,1H3,(H,17,22);1-2H3.
What are the key properties of Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine?
Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine has a molecular weight of 361.41 g/mol, XLogP of 2.94, 3 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for Ethane;3-(1-methylpyrazol-4-yl)-N-([1,2,4]triazolo[1,5-a]pyridin-8-yl)imidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 143464724), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.